Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes

The luminal A-subtype of breast cancer, where the oestrogen receptor α (ERα) is overexpressed, is the most frequent one. The prodrug tamoxifen (<b>1</b>) is the clinically used agent, inhibiting the ERα activity via the formation of several active metabolites, such as 4-hydroxytamoxifen...

Full description

Saved in:
Bibliographic Details
Main Authors: Aleksandr Kazimir (Author), Benedikt Schwarze (Author), Peter Lönnecke (Author), Sanja Jelača (Author), Sanja Mijatović (Author), Danijela Maksimović-Ivanić (Author), Evamarie Hey-Hawkins (Author)
Format: Book
Published: MDPI AG, 2023-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available